By KATIE THOMAS
The drugmaker’s decision to sell a generic version comes with the industry under pressure to do something about rising list prices.
Published: March 3, 2019 at 07:00PM
from NYT Health https://ift.tt/2ITf1Dt
via IFTTT
from WordPress https://ift.tt/2XzAx3q
via IFTTT
No comments:
Post a Comment